Chemung Financial (CMHG) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Net income for Q3 2024 was $5.7 million ($1.19 per share), down 25% year-over-year but up from $5.0 million in Q2 2024; nine-month net income was $17.8 million ($3.72 per share), down 16%.
Return on average equity for Q3 was 10.81%, compared to 16.89% in Q3 2023; nine-month ROE was 11.82%.
Balance sheet remains strong entering a rate-cutting cycle, with higher yielding loans boosting interest income and moderating funding costs.
Decrease in net income driven by lower non-interest income, higher non-interest expense, and increased provision for credit losses, partially offset by higher net interest income and lower tax expense.
Opened a new full-service branch in Williamsville, NY, expanding regional presence.
Financial highlights
Net interest income for Q3 2024 was $18.4 million, up 2.1% year-over-year and 3.4% sequentially; nine-month net interest income fell 4.1% to $54.2 million.
Non-interest income for Q3 was $5.9 million, up 5.4% sequentially but down 24% year-over-year due to absence of prior year ERTC recognition; nine-month non-interest income fell 8%.
Non-interest expense increased 5.4% year-over-year in Q3 and 4.2% for the nine months, mainly from higher compensation and data processing.
Provision for credit losses was $0.6 million in Q3, up from $0.4 million last year but down $0.3 million sequentially; nine-month provision was a credit of $0.6 million.
Total assets grew 2.3% since year-end to $2.77 billion; loans rose 2.9% to $2.03 billion; deposits up 0.9% to $2.45 billion.
Outlook and guidance
Management expects continued pressure on net interest margin due to higher funding costs and competitive deposit environment, but also expects to benefit from higher yielding loans and moderating funding costs.
Loan growth is anticipated to remain concentrated in commercial real estate and C&I segments, with residential mortgage demand subdued.
Brokered deposits will continue as a secondary funding source to support growth.
Ongoing focus on community-oriented banking and regional expansion.
Asset quality remains stable, but management is monitoring economic conditions and credit trends closely.
Latest events from Chemung Financial
- All proposals passed; strong 2023 results, expansion, and dividends highlighted.CMHG
AGM 202431 Jan 2026 - Annual non-GAAP net income rose 17.8% to $27.9M, driven by strong loan growth and margin gains.CMHG
Q4 202526 Jan 2026 - Board recommends FOR all proposals, including director elections and new equity plan.CMHG
Proxy Filing2 Dec 2025 - Virtual meeting to elect directors, approve pay, equity plan, and auditor ratification.CMHG
Proxy Filing2 Dec 2025 - All proposals, including director elections and compensation, were approved by majority vote.CMHG
AGM 202526 Nov 2025 - Q3 net income up 36% year-over-year, with strong loan growth and improved margins.CMHG
Q3 20256 Nov 2025 - Net income declined 21% year-over-year as margin pressure persisted, but capital and lending improved.CMHG
Q2 20249 Oct 2025 - Adjusted net income reached $6.3M as capital moves offset a $17.5M securities loss.CMHG
Q2 20257 Aug 2025 - 2024 net income fell 5.3% to $23.7M as higher expenses offset loan growth.CMHG
Q4 20249 Jun 2025